ATE223215T1 - Inhibitoren der fettsäuresynthese als antimikrobielle mittel - Google Patents
Inhibitoren der fettsäuresynthese als antimikrobielle mittelInfo
- Publication number
- ATE223215T1 ATE223215T1 AT95909239T AT95909239T ATE223215T1 AT E223215 T1 ATE223215 T1 AT E223215T1 AT 95909239 T AT95909239 T AT 95909239T AT 95909239 T AT95909239 T AT 95909239T AT E223215 T1 ATE223215 T1 AT E223215T1
- Authority
- AT
- Austria
- Prior art keywords
- fatty acid
- acid synthesis
- inhibitors
- fas
- cells
- Prior art date
Links
- 230000004136 fatty acid synthesis Effects 0.000 title abstract 3
- 239000004599 antimicrobial Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000015303 Fatty Acid Synthases Human genes 0.000 abstract 4
- 108010039731 Fatty Acid Synthases Proteins 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/188,421 US5614551A (en) | 1994-01-24 | 1994-01-24 | Inhibitors of fatty acid synthesis as antimicrobial agents |
PCT/US1995/000544 WO1995019706A1 (en) | 1994-01-24 | 1995-01-24 | Inhibitors of fatty acid synthesis as antimicrobial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE223215T1 true ATE223215T1 (de) | 2002-09-15 |
Family
ID=22693071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95909239T ATE223215T1 (de) | 1994-01-24 | 1995-01-24 | Inhibitoren der fettsäuresynthese als antimikrobielle mittel |
Country Status (13)
Country | Link |
---|---|
US (1) | US5614551A (de) |
EP (1) | EP0738107B1 (de) |
JP (1) | JPH09508370A (de) |
KR (1) | KR100395601B1 (de) |
AT (1) | ATE223215T1 (de) |
AU (1) | AU703272B2 (de) |
CA (1) | CA2181031A1 (de) |
DE (1) | DE69528039T2 (de) |
DK (1) | DK0738107T3 (de) |
ES (1) | ES2182888T3 (de) |
MX (1) | MX9602934A (de) |
PT (1) | PT738107E (de) |
WO (1) | WO1995019706A1 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6010881A (en) * | 1996-02-20 | 2000-01-04 | Smithkline Beecham Corporation | RibG |
US5859027A (en) * | 1996-02-26 | 1999-01-12 | Chektec Corporation | Antimicrobial agent |
US5910509A (en) * | 1996-06-20 | 1999-06-08 | Broedel; Sheldon E. | Antimicrobial agent for agriculture |
EP0918868A2 (de) * | 1996-07-19 | 1999-06-02 | Arch Development Corporation | Antimikrobielle mittel, diagnostische reagenzien und impfstoffe auf der grundlage einzigartiger apicomplexanparasitenkomponenten |
US5750496A (en) * | 1996-08-12 | 1998-05-12 | Utah State University | Method of controlling cryptosporidium infectons using protease inhibitors |
WO1998006734A1 (en) * | 1996-08-16 | 1998-02-19 | Smithkline Beecham Corporation | Novel prokaryotic polynucleotides, polypeptides and their uses |
US20050112713A1 (en) * | 1996-08-28 | 2005-05-26 | Affinium Pharmaceuticals, Inc. | Methods of using Fab I and compounds modulating Fab I activity |
US6995254B1 (en) | 1996-08-28 | 2006-02-07 | Affinium Pharmaceuticals, Inc. | Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I |
US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
US5859028A (en) * | 1997-04-28 | 1999-01-12 | Potomax Limited Partnership | Carotenoid synthesis inhibiting herbicides and fatty acid synthesis inhibiting oxime herbicides as anti-Apicomplexa protozoan parasite agents |
US6171856B1 (en) | 1997-07-30 | 2001-01-09 | Board Of Regents, The University Of Texas System | Methods and compositions relating to no-mediated cytotoxicity |
US6713654B1 (en) * | 1997-08-29 | 2004-03-30 | The Johns Hopkins University School Of Medicine | Antimicrobial compounds |
EP1007509B1 (de) * | 1997-08-29 | 2004-03-03 | The Johns Hopkins University | Antimikrobielle verbindungen |
CO5180550A1 (es) | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | Inhibidores de fab i |
AR024158A1 (es) | 1999-06-01 | 2002-09-04 | Smithkline Beecham Corp | Compuestos antibacterianos |
US7279007B2 (en) * | 1999-08-09 | 2007-10-09 | Cardioklnetix, Inc. | Method for improving cardiac function |
EP1206463A4 (de) * | 1999-08-23 | 2003-01-29 | Smithkline Beecham Corp | Inhibitoren der fettsäuresynthase |
US6730684B1 (en) | 1999-10-08 | 2004-05-04 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
US6762201B1 (en) | 1999-10-08 | 2004-07-13 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
JP4803935B2 (ja) * | 1999-10-08 | 2011-10-26 | アフィニアム・ファーマシューティカルズ・インコーポレイテッド | Fabi阻害剤 |
WO2001030988A1 (en) * | 1999-10-27 | 2001-05-03 | Smithkline Beecham Corporation | Methods for making and using fatty acid synthesis pathway reagents |
US6951729B1 (en) | 1999-10-27 | 2005-10-04 | Affinium Pharmaceuticals, Inc. | High throughput screening method for biological agents affecting fatty acid biosynthesis |
US6656703B1 (en) * | 1999-12-29 | 2003-12-02 | Millennium Pharamaceuticals, Inc. | High throughput screen for inhibitors of fatty acid biosynthesis in bacteria |
AU2761101A (en) * | 2000-01-07 | 2001-07-24 | Virginia Commonwealth University | A scintillation proximity assay for type ii fatty acid biosynthetic enzymes |
EP1259121A2 (de) * | 2000-02-16 | 2002-11-27 | The Johns Hopkins University School Of Medicine | Gewichtabnahme, induziert durch reduzierung des neuropeptid-y-spiegels |
US20040157918A1 (en) * | 2001-02-16 | 2004-08-12 | Loftus Thomas M. | Weight loss induced by reduction in neuropeptide y level |
WO2001071045A2 (en) * | 2000-03-23 | 2001-09-27 | Millennium Pharmaceuticals, Inc. | High throughput screening for inhibitors of fatty acid, ergosterol, sphingolipid, or phospholipid synthesis in fungi |
US7048926B2 (en) * | 2000-10-06 | 2006-05-23 | Affinium Pharmaceuticals, Inc. | Methods of agonizing and antagonizing FabK |
DE60230934D1 (de) * | 2001-04-06 | 2009-03-05 | Affinium Pharm Inc | Fab-i-inhibitoren |
US7348023B2 (en) * | 2001-11-21 | 2008-03-25 | Kimberly-Clark Worldwide, Inc. | Absorbent articles containing additives |
US6821999B2 (en) * | 2001-11-21 | 2004-11-23 | Kimberly-Clark Worldwide, Inc. | Methods for inhibiting the production of TSST-1 |
US7323186B2 (en) * | 2001-11-21 | 2008-01-29 | Kimberly-Clark Worldwide, Inc. | Non-absorbent articles containing additives |
US6955890B2 (en) * | 2002-02-14 | 2005-10-18 | Pyro Pharmaceuticals, Inc. | Method for the identification and treatment of pathogenic microorganisms infections by inhibiting one or more enzymes in an essential metabolic pathway |
US20060063224A1 (en) * | 2002-05-10 | 2006-03-23 | Schechter Alan M | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway |
US7649012B2 (en) * | 2002-07-09 | 2010-01-19 | Fasgen, Inc. | Compounds, pharmaceutical compositions containing same, and methods of use for same |
ES2518316T3 (es) * | 2002-12-06 | 2014-11-05 | Debiopharm International Sa | Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia |
WO2004082586A2 (en) | 2003-03-17 | 2004-09-30 | Affinium Pharmaceuticals, Inc. | Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
WO2005005469A2 (en) * | 2003-07-11 | 2005-01-20 | Affinium Pharmaceuticals, Inc. | Novel purified polypeptides from staphylococcus aureus |
JP2008500363A (ja) * | 2004-05-26 | 2008-01-10 | ファスジェン・リミテッド・ライアビリティ・カンパニー | 新規化合物、該化合物を含む医薬組成物、および該化合物の使用方法 |
PT1828167E (pt) * | 2004-06-04 | 2014-10-08 | Debiopharm Int Sa | Derivados de acrilamida como agentes antibióticos |
KR20080075027A (ko) * | 2005-12-05 | 2008-08-13 | 아피늄 파마슈티컬스, 인크. | Fabi 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물 |
WO2007092590A2 (en) * | 2006-02-08 | 2007-08-16 | Fasgen, Inc. | Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa) |
WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
EP3255045A1 (de) | 2007-02-16 | 2017-12-13 | Debiopharm International SA | Salze, prodrugs und polymorphe von fab i-inhibitoren |
AU2008287542C1 (en) * | 2007-06-01 | 2015-01-22 | The Trustees Of Princeton University | Treatment of viral infections by modulation of host cell metabolic pathways |
US8729239B2 (en) | 2009-04-09 | 2014-05-20 | Nuclea Biotechnologies, Inc. | Antibodies against fatty acid synthase |
LT2861608T (lt) | 2012-06-19 | 2019-07-10 | Debiopharm International Sa | (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-nafthidrin-3-il)akrilamido provaisto dariniai |
BR102012033811A8 (pt) * | 2012-12-28 | 2019-12-24 | Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs | compostos, uso, composição farmacêutica inibidora de redutase em microorganismos, ligante de inha, e, método para obtenção de ligantes de inha |
BR102013006007A2 (pt) * | 2013-03-13 | 2014-11-11 | Ubea | Compostos, uso, composição farmacêutica inibidora de redutase em microorganismos, ligante de inha, e, método para obtenção de ligantes de inha a partir de derivados de acetamida, ureia, fenol e carboxamida |
HUE052140T2 (hu) | 2016-02-26 | 2021-04-28 | Debiopharm Int Sa | Diabéteszes lábfertõzések kezelésére szolgáló gyógyszer |
EP3266454A1 (de) * | 2016-07-07 | 2018-01-10 | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften | Acc-hemmer zur verwendung bei der behandlung von mycobakteriellen erkrankungen |
US20210137934A1 (en) * | 2017-03-16 | 2021-05-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of identifying myc-driven and lipogenesis-dependent neoplasms and methods of treating the same |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE252616C (de) * | 1912-01-25 | 1912-10-23 | Gebr Lesser | Ablegerad für Kartoffelerntemaschinen mit einem quer zur Fahrrichtung de Maschine umlaufenden Wurfrad |
US3630846A (en) * | 1967-09-01 | 1971-12-28 | Kitasato Inst And Toyo Jozo Kk | Antibiotic production using streptomyces kitasatoensis |
US3535309A (en) * | 1967-09-01 | 1970-10-20 | Kitasato Inst | Antibiotics and their production |
US3909361A (en) * | 1971-06-29 | 1975-09-30 | Nihon Tokushu Noyaku Seizo Kk | Novel antifungal antibiotic substance, process for production of the same, and agricultural and horticultural fungicidal composition containing said substance |
JPS5619344B2 (de) * | 1972-11-11 | 1981-05-07 | ||
US4011334A (en) * | 1975-10-03 | 1977-03-08 | Richardson-Merrell Inc. | Use of substituted furan and thiophene carboxaldehydes as hypolipidemic agents |
US4602099A (en) * | 1973-04-02 | 1986-07-22 | Merrell Dow Pharmaceuticals Inc. | Antirhinovirus agents |
US4110351A (en) * | 1973-04-02 | 1978-08-29 | Richardson-Merrell Inc. | Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts |
US4738984A (en) * | 1973-04-02 | 1988-04-19 | Merrell Dow Pharmaceuticals Inc. | Antirhinovirus agents |
US4000164A (en) * | 1973-04-02 | 1976-12-28 | Richardson-Merrell Inc. | Hypolipidemic agents |
US4032647A (en) * | 1975-06-16 | 1977-06-28 | Richardson-Merrell Inc. | Substituted thenoylacetic acid and esters |
US4328246A (en) * | 1979-08-14 | 1982-05-04 | Joseph Gold | Anti Walker 256 carcinoma agent and combination thereof |
JPS59225115A (ja) * | 1983-06-06 | 1984-12-18 | Ota Seiyaku Kk | 青魚類から得た長鎖高度不飽和脂肪酸を含有する微細カプセル |
JPS6058917A (ja) * | 1983-09-09 | 1985-04-05 | Rikagaku Kenkyusho | 制癌剤 |
FR2552879B1 (fr) * | 1983-10-03 | 1987-08-14 | Pasteur Institut | Procede et reactifs pour la detection d'une anomalie genetique dans une matiere biologique, notamment dans une preparation de leucocytes |
CA1256372A (en) * | 1985-04-11 | 1989-06-27 | Koichiro Miyazima | Process for producing liposome composition |
US5110731A (en) * | 1985-08-26 | 1992-05-05 | Amgen, Inc. | System for biotin synthesis |
US4789630A (en) * | 1985-10-04 | 1988-12-06 | Cetus Corporation | Ionic compounds containing the cationic meriquinone of a benzidine |
GB8607137D0 (en) * | 1986-03-21 | 1986-04-30 | Efamol Ltd | Compositions |
US5185149A (en) * | 1987-03-27 | 1993-02-09 | Merck & Co., Inc. | Methods for thrombolytic therapy |
US4968494A (en) * | 1987-03-27 | 1990-11-06 | Merck & Co., Inc. | Methods and compositions for thrombolytic therapy |
US5188830A (en) * | 1987-03-27 | 1993-02-23 | Merck & Co., Inc. | Methods for thrombolytic therapy |
JPH01132542A (ja) * | 1987-11-19 | 1989-05-25 | Toomen:Kk | ゴッシポールラセミ体の光学分割法 |
US4877782A (en) * | 1988-02-16 | 1989-10-31 | The Upjohn Company | Zinc ceftiofur complexes |
JPH02113850A (ja) * | 1988-10-21 | 1990-04-26 | Nippon Oil & Fats Co Ltd | 発癌抑制用油脂組成物 |
US5190969A (en) * | 1988-12-20 | 1993-03-02 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | 2,3-epoxy derivatives as anti retrovital chemotherapeutic agents |
AU621434B2 (en) * | 1988-12-21 | 1992-03-12 | Merrell Dow Pharmaceuticals Inc. | Antiretroviral furan ketones |
JPH02247125A (ja) * | 1989-03-17 | 1990-10-02 | Koken Kk | 悪性腫瘍細胞増殖抑制剤 |
US5143907A (en) * | 1991-05-10 | 1992-09-01 | Boron Biologicals, Inc. | Phosphite-borane compounds, and method of making and using the same |
US5858784A (en) * | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
AU3467193A (en) * | 1991-12-17 | 1993-07-19 | Regents Of The University Of California, The | Gene therapy for cystic fibrosis transmembrane conductance regulator activity (CFTR) |
MX9304501A (es) * | 1992-07-24 | 1994-04-29 | Univ Johns Hopkins | Quimioterapia para cancer. |
US5539132A (en) * | 1994-01-24 | 1996-07-23 | Johns Hopkins University | Cerulenin compounds for fatty acid synthesis inhibition |
-
1994
- 1994-01-24 US US08/188,421 patent/US5614551A/en not_active Expired - Lifetime
-
1995
- 1995-01-24 WO PCT/US1995/000544 patent/WO1995019706A1/en active IP Right Grant
- 1995-01-24 DK DK95909239T patent/DK0738107T3/da active
- 1995-01-24 EP EP95909239A patent/EP0738107B1/de not_active Expired - Lifetime
- 1995-01-24 AU AU17268/95A patent/AU703272B2/en not_active Ceased
- 1995-01-24 JP JP7519612A patent/JPH09508370A/ja not_active Ceased
- 1995-01-24 CA CA002181031A patent/CA2181031A1/en not_active Abandoned
- 1995-01-24 DE DE69528039T patent/DE69528039T2/de not_active Expired - Fee Related
- 1995-01-24 KR KR1019960703954A patent/KR100395601B1/ko not_active IP Right Cessation
- 1995-01-24 AT AT95909239T patent/ATE223215T1/de not_active IP Right Cessation
- 1995-01-24 MX MX9602934A patent/MX9602934A/es not_active IP Right Cessation
- 1995-01-24 PT PT95909239T patent/PT738107E/pt unknown
- 1995-01-24 ES ES95909239T patent/ES2182888T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0738107A1 (de) | 1996-10-23 |
EP0738107A4 (de) | 1998-09-09 |
ES2182888T3 (es) | 2003-03-16 |
DK0738107T3 (da) | 2003-01-06 |
WO1995019706A1 (en) | 1995-07-27 |
PT738107E (pt) | 2003-01-31 |
AU703272B2 (en) | 1999-03-25 |
DE69528039T2 (de) | 2003-08-07 |
CA2181031A1 (en) | 1995-07-27 |
MX9602934A (es) | 1997-12-31 |
EP0738107B1 (de) | 2002-09-04 |
JPH09508370A (ja) | 1997-08-26 |
US5614551A (en) | 1997-03-25 |
DE69528039D1 (de) | 2002-10-10 |
KR100395601B1 (ko) | 2003-11-17 |
AU1726895A (en) | 1995-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE223215T1 (de) | Inhibitoren der fettsäuresynthese als antimikrobielle mittel | |
DE69907508T2 (de) | Mikrobenbeständige und stabilisierte lösungen, die gamma-hydroxybuttersäuresalze zur behandlung von narkolepsie enthalten | |
AU2005202257C1 (en) | Azacyclic compounds for use in the treatment of serotonin related diseases | |
GB0105772D0 (en) | Use | |
AU1373499A (en) | Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease | |
AU3804500A (en) | 2-amino-6-anilino-purines and their use as medicaments | |
MY120235A (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
ATE231837T1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
DE69931809D1 (de) | Antibakterielle protonierte oligonukleotide | |
ATE225167T1 (de) | Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs | |
AU8647101A (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
DE60039601D1 (de) | Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit | |
AU2001245319A1 (en) | Methods of treating diseases with activated protein c | |
DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
DE50114181D1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz | |
BRPI0413684A (pt) | compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos | |
DE50103012D1 (de) | Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen | |
SI1596879T1 (sl) | Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice | |
WO2002067851A3 (en) | Method for treating fibrotic diseases or other indications iiic | |
AU2900100A (en) | Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss | |
HUP9801925A1 (hu) | Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
DE69630523D1 (de) | Verwendung von Calciumkanalanantagonisten zur Behandlung von Herz-, Nieren-, Magen-und Darmkrankheiten sowie Bluthochdruck | |
ES2164013A1 (es) | Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales. | |
TW200503624A (en) | Preventive for plant disease and a method for preventing plant disease using the same | |
SE9903609D0 (sv) | Novel compounds I |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0738107 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |